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Background. The inner medullary collecting duct (IMCD) is composed
of at least two functionally and morphologically distinct segments, the
initial (IMCDi) and the terminal (IMCDt) portions. However, most
studies of receptor signaling have been performed on cells obtained from
the entire inner medulla. The purpose of this study was to determine
whether the patterns of receptor-activated cAMP accumulation were
different between these segments.
Methods. We measured cAMP accumulation stimulated by vasopressin
and isoproterenol, and the effect of epinephrine in freshly dissected
IMCDi and IMCDt segments cultured and IMCDi and IMCDt cells in
primary culture.
Results. The maximum response to vasopressin was twofold higher in
fresh IMCDt versus IMCDi (P , 0.05), however, it increased in cultured
IMCDi by 40% versus fresh cells with no change in the response in fresh
versus cultured IMCDt. The maximum response to isoproterenol was
small in fresh cells but increased by five- and sixfold, respectively, in
cultured IMCDi and IMCDt cells. a2-Adrenoceptor stimulation almost
completely inhibited both vasopressin and isoproterenol-stimulated
cAMP accumulations in fresh IMCDi and IMCDt cells, but only partially
inhibited either accumulation by 34 to 49% in cultured cells.
Conclusions. (1) IMCDi and IMCDt cells are both subject to vasopres-
sin and a2- and b-adrenergic regulation of adenylyl cyclase activity; (2) the
relative influence of b-adrenergic, a2-adrenergic and V2 receptors to
affect cAMP accumulation is altered in primary culture versus freshly
dissected IMCD segments, suggesting that caution must be exercised in
the extrapolation of data from cultured IMCD cells to in vivo models.
The inner medullary collecting duct (IMCD) is the site of
final adjustment of the urinary composition. Recent studies
in rats and rabbits have demonstrated cellular and func-
tional heterogeneity within the IMCD. Morphologically,
the cells of the first 20 to 30% of the IMCD contain cells
that resemble the principal cells of the inner stripe of the
outer medulla and a small (;10%) population of interca-
lated cells [1–3]. Functionally, this segment has low basal
water and urea permeabilities [4, 5]. Under the influence of
vasopressin, the water but not urea permeability increases
many-fold. This segment has been referred to as the initial
IMCD (IMCDi) [5]. The terminal portion (IMCDt) is
populated by a morphologically unique cell type, the IMCD
cell [2]. This segment has somewhat higher baseline water
and urea permeabilities than the IMCDi; however, stimu-
lation with vasopressin causes both urea and water perme-
abilities to increase [4, 5] via distinct cAMP-dependent
mechanisms [6, 7].
a2- and b-Adrenoceptors are found throughout the rat
collecting tubule. In the cortical collecting duct, a2-adreno-
ceptors have been localized to principal cells where they
inhibit vasopressin-stimulated cellular adenosine 39,59-cy-
clic monophosphate (cAMP) accumulation and water and
Na reabsorption [reviewed in 8]. Inhibitory a2-adrenocep-
tors are also expressed by cultured rat IMCD cells [9].
These receptors are of the a2B subtype [10]. However, it is
unknown whether functional a2-adrenoceptors reside in
both the IMCDi and IMCDt. b-Adrenoceptor stimulation
increases cAMP production in intercalated cells of the
cortical and outer medullary collecting ducts which in turn
decreases Cl2 transport [11] and increases K1 secretion
[12]. b-Adrenoceptor stimulation has been reported to
increase cAMP production in cultured IMCD cells [9] but
no associated role in renal transport has been described.
We have recently shown that cultured rat IMCD cells
express b-adrenoceptors of the b1 and b2 subtypes [13].
The regional distribution of functional b-adrenoceptors has
not fully been investigated within segments of the IMCD.
Despite the fact that the cells of the IMCDi and IMCDt
are functionally and morphologically distinct, little is
known about how these segments differ with respect to
signal transduction. Most of our information on adenylyl
cyclase regulation in IMCD cells comes from cultured cell
models which use cells derived from both IMCDi and
IMCDt segments. The purpose of this investigation was
thus threefold: (1) to investigate the characteristics of
vasopressin-stimulated cAMP accumulation in IMCDi ver-
sus IMCDt segments; (2) to determine whether a2-adreno-
ceptors and b-adrenoceptors were present in both IMCDi
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and IMCDt segments; (3) to study the differences in
regulation of cAMP production in cultured versus fresh
IMCDi and IMCDt segments. The results revealed that
despite differences in morphology and function, both the
terminal and the initial portions of the IMCD are subject to
b- and a2-adrenergic regulation. However, our results
indicate that care must be exercised in the interpretation of
results obtained from cultured IMCD cells, since important
quantitative differences in signaling were found in fresh
versus cultured cells.
METHODS
Isolation of IMCDi and IMCDt cells
Inner medullae were removed in a sterile hood from
anesthetized (pentobarbital Na, 50 mg/kg) male Sprague-
Dawley rats. The kidneys were cut sagittaly and the upper
one-fourth of the inner medulla, which contained the
IMCDi segments, and the lower one-third of the inner
medulla, which contained the IMCDt segments, were care-
fully dissected. The middle section was discarded. The cells
from each region were isolated using a combination of
collagenase digestion and osmotic shock as described by
Sato and Dunn [14]. Isolated cells were either prepared for
primary culture or were used immediately for experiments
as described below.
Cell culture
Detailed methods are published elsewhere [10, 15]. Cells
were seeded in collagen-coated 96-well plates, at a density
of ;50,000 cells/well in 50 ml of culture medium and
incubated in an atmosphere of 5% CO2 at 37°C. The
medium was a 1:1 mixture of Dulbecco’s modified Eagle’s
medium (DMEM) and Ham’s F-12 medium that contained
10 mM N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic
acid (HEPES), 42 mM sodium bicarbonate, 100 U/ml
penicillin G, 100 mg/ml streptomycin sulfate, 0.1 mM MEM
nonessential amino acids, 0.1 mM sodium pyruvate, 2 mM
l-glutamine, 20 mg/liter gentamicin, and 10% fetal bovine
serum. After 48 hours in culture, the serum-containing
medium was replaced with a defined serum-free medium
that contained a 1:1 mixture of DMEM and Ham’s F-12
with 10 mM HEPES, 42 mM sodium bicarbonate, 100 U/ml
penicillin G, 100 mg/ml streptomycin sulfate, 5 mg/ml
insulin, 50 nM hydrocortisone, 5 mg/ml transferrin, 5 pM
triiodothyronine, and 10 nM sodium selenite. The medium
was changed daily thereafter and cells were used in assays
after five days in culture. The identity of the cultured cell
types was confirmed using scanning electron microscopy.
Virtually all of the cells observed that were isolated from
the initial portion of the inner medulla possessed single
central cilia, indicative of principal cells [16]. The cells
cultured from the lower third of the medulla possessed an
epithelial-like morphology but were not ciliated.
cAMP assay
In cultured cells, growth media were removed one hour
prior to the assay and replaced with 50 ml of Hanks’
balanced salt solution (GIBCO, Gaithersburg, MD, USA)
that contained 0.5 mM MgCl2z6H2O, 0.4 mM MgSO4z7H2O,
20 mM HEPES, 1.2 mM 3-isobutyl-1-methylxanthine, 0.95
mM CaCl2, and 0.05% bovine serum albumin. Freshly
isolated cells were suspended in the same Hanks’ solution
and were aliquoted into 96-well plates. Each plate was
placed in a shaking water bath at 37°C for dose-response
studies. In one study, various doses of vasopressin (10211 to
1026 M) and isoproterenol (1029 to 1025 M) were added (5
wells/concentration/plate) and incubated for 10 minutes.
To evaluate a2-adrenoceptor activity, cells were stimulated
with 3 3 1027 M vasopressin in the presence or absence of
various concentrations of epinephrine and in the presence
of both epinephrine (1025 M) and rauwolscine (1025 M).
dl-Propranolol (1026 M) was added in vasopressin studies
using epinephrine to prevent concomitant activation of
b-adrenoceptors. In other studies, cells were stimulated
with 1025 M isoproterenol in the presence or absence of
various concentrations of epinephrine. No propranolol was
present in these latter experiments. The incubations were
terminated after 10 minutes by adding 100 ml of 10%
trichloroacetic acid (TCA; final concentration of 5%). TCA
was removed by two extractions with H2O-saturated ether
and samples were dried at 80°C overnight, then resus-
pended in 50 mM sodium acetate buffer. The cAMP content
was measured by radioimmunoassay using a kit (New
England Nuclear, Boston, MA, USA).
Materials
The following compounds were purchased from the
Sigma Chemical (St. Louis, MO, USA): (-)epinephrine
bitartrate salt, l-isoproterenol bitartrate, dl-propranolol
HCl, 3-isobutyl-1-methylxanthine, [Arg8]-vasopressin
Grade VI, collagenase (type II). DMEM, Ham’s F-12,
HEPES, penicillin G, streptomycin sulfate, gentamicin,
I-glutamine, sodium pyruvate, nonessential amino acids,
fetal bovine serum, insulin, hydrocortisone, transferrin,
triiodothyronine and sodium selenite were purchased from
GIBCO. Rauwolscine HCl was purchased from Accurate
Chemicals (Westbury, CT, USA).
Statistics
All results were expressed as means 6 SEM. Group means
were compared where appropriate with the two tailed
Student’s t-test [17]. The statistical significance was evalu-
ated at the 95% confidence level. Concentration-response
data were subjected to iterative non-linear regression anal-
ysis using GraphPad Prism (version 2.01, GraphPad Soft-
ware Inc.). Values for maximum response and half-maxi-
mal effective concentration (EC50) agonists were calculated
from the fitted regression curves [17].
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RESULTS
Response to vasopressin (V2)-receptor stimulation. In
freshly isolated cells, vasopressin caused a concentration-
related rise in cAMP formation (Fig. 1A). Interestingly, the
maximum response to vasopressin was approximately two-
fold higher in IMCDt cells versus IMCDi cells (Table 1). In
cultured cells vasopressin also caused a concentration-
related rise in cAMP formation (Fig. 1B). However, the
maximum response of IMCDi cells in culture to vasopressin
was higher compared to fresh IMCDi cells, whereas the
response to vasopressin was similar in fresh and cultured
IMCDt cells (compare Fig. 1 A and B). No difference was
noted in the maximum response to vasopressin between
cultured cells originating from IMCDi and IMCDt (Fig.
1B). The EC50 of vasopressin was not different between
IMCDi and IMCDt cells (Table 1); however, the EC50
shifted rightward by 8.5 (IMCDi) and 7.2 (IMCDt) fold in
cultured versus fresh cells.
Response to b-adrenoceptor stimulation. Isoproterenol
elicited a small concentration-related response from freshly
isolated cells (Fig. 2A). The maximum responses to isopro-
terenol in fresh cells were 17.1-fold (IMCDi) and 40.5-fold
(IMCDt) lower than the response to vasopressin in the
same segments. Maximum responses and EC50 values for
isoproterenol were not significantly different between seg-
ments (Table 1). In cultured cells, the maximum responses
to isoproterenol were 5- (IMCDi) and 7-fold (IMCDt)
larger than those found in freshly isolated cells (Fig. 2B).
EC50 values between cultured IMCDi and IMCDt cells
were similar (Table 1).
Response to a2-adrenoceptor stimulation. In freshly
isolated IMCD cells, epinephrine (in the presence of
propranolol) caused a nearly complete inhibition of vaso-
pressin-stimulated (3 3 1027 M) cAMP formation (Fig. 3A
and Table 1). No significant difference was observed in the
maximum response or EC50 values for a2-adrenoceptor
stimulation between IMCDi and IMCDt. In cultured cells
there were again no differences between cell types but the
maximum inhibitory response to epinephrine was blunted
by 44 to 52% compared to fresh cells (Fig. 3B). The
inhibitory response to epinephrine was shown to be medi-
ated by a2-adrenoceptors in both IMCDi and IMCDt cells
in culture because the specific a2-adrenoceptor antagonist
rauwolscine completely prevented epinephrine-induced in-
hibition of the response to vasopressin. During these
experiments, IMCDi (N 5 5 experiments) and IMCDt
(N 5 6 experiments) were incubated with 3 3 1027 M
vasopressin, vasopressin plus epinephrine (1026 M), and
vasopressin plus epinephrine plus rauwolscine (1025 M).
Epinephrine alone significantly inhibited the response to
vasopressin by 38 6 7% (IMCDi) and 30 6 3% (IMCDt).
In the presence of rauwolscine, cAMP accumulation was
105 6 3% (IMCDi) and 98 6 3% (IMCDt) of the response
to vasopressin alone. a2-Adrenoceptor stimulation with
Fig. 1. Vasopressin (AVP)-stimulated cAMP
accumulation in initial (IMCDi; F) and
terminal (IMCDt; E) inner medullary
collecting duct cells. (A) Freshly isolated cells.
Each point represents the mean of three
experiments 6 SEM. Each experiment was
performed in quintuplicate. *P , 0.05 for
IMCDi versus IMCDt, Students t-test. (B) Cells
in primary culture. Cells were cultured in 96-
well plates for five days as described in the text.
Each point represents the mean of at 3 to 10
experiments 6 SEM. Each experiment was
performed in quintuplicate.
Table 1. Half-maximal-effective concentration (EC50) values and
maximum responses to modulators of adenylyl cyclase activity in initial
(IMCDi) and terminal (IMCDt) IMCD cells
Agonist Segment
Cultured cells Fresh cells
EC50
nM Max responsea
EC50
nM Max response
Vasopressin IMCDi 6.8 917 6 83 0.8 655 6 36b
IMCDt 5.1 1315 6 164 0.7 1236 6 62
Isoproterenol IMCDi 75 189 6 9 29 38.3 6 5.6
IMCDt 107 213 6 11 70 30.5 6 4.7
Epinephrine IMCDi 24 49 6 8% 20 94 6 7%
IMCDt 20 34 6 5% 20 77 6 6%
a Maximum responses to vasopressin and isoproterenol are measured in
pmol cAMP/106 cells; max response for epinephrine is % inhibition of
vasopressin (331027 M)-stimulated cAMP accumulation. Values for max-
imum response were determined from non-linear regression of the
concentration-response curves shown in Figures 1-3.
b P , 0.05 vs. IMCDt
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epinephrine also reduced the response to isoproterenol-
induced cAMP formation in fresh and cultured cells (Fig.
4). The pattern of responses was similar to that seen for
inhibition of vasopressin-stimulated cAMP accumulation;
however, the responses in fresh cells (Fig. 4A) were quite
variable due to the small baseline responses to isoprotere-
nol (see Fig. 2A).
DISCUSSION
Most of our current knowledge of the regulation of signal
transduction in the inner medulla comes from studies using
primary cell culture or collecting duct cell lines. To our
knowledge, studies involving primary cell culture have
always used the entire inner medulla as a source for
epithelial cells of IMCD origin. Signal transduction and
receptor expression have been well characterized in these
cells [9, 10, 14, 18, 19]. However, in the light of the recently
discovered morphological and functional heterogeneity of
the IMCD, it has become apparent that these cell popula-
tions must be studied separately in order to understand
regulation of adenylyl cyclase by hormones and neurotrans-
mitters in the IMCD. Further, since phenotypic alterations
can occur in culture, it was necessary to quantitatively
compare responses in cultured versus freshly isolated
IMCDi and IMCDt cells to validate the cell culture ap-
proach. Thus, in the present study we investigated the
primary known hormonal modulators of adenylyl cyclase
activity in the IMCD, vasopressin and the catecholamines.
Our results revealed heterogeneity of agonist-stimulated
cAMP accumulation as well as important distinctions in
freshly isolated versus cultured cells.
Vasopressin stimulates water transport in both IMCDi
Fig. 2. Isoproterenol-stimulated cAMP
accumulation in initial (IMCDi; F) and
terminal (IMCDt; E) inner medullary
collecting duct cells. (A) Freshly isolated cells.
Each point represents the mean of three
experiments 6 SEM. Each experiment was
performed in quintuplicate. (B) Cells in primary
culture. Cells were cultured in plastic 96-well
plates for five days as described in the text.
Each point represents the mean of 3 to 10
experiments 6 SEM. Each experiment was
performed in quintuplicate.
Fig. 3. Inhibition of vasopressin (AVP)-
stimulated cAMP accumulation by a2-
adrenoceptor stimulation in initial (IMCDi; F)
and terminal (IMCDt; E) inner medullary
collecting duct cells. (A) Freshly isolated cells.
Each point represents the response of 3 3 1027
M vasopressin plus the indicated concentrations
of epinephrine. The response for vasopressin
alone (100%) was 648 6 101 pmol/106 cells in
initial IMCD segments and 1260 6 161 pmol/
106 cells in terminal IMCD segments. Each
point represents the mean of 3 experiments 6
SEM. Each experiment was performed in
quintuplicate. (B) Cells in primary culture.
Each point represents the response of 3 3 1027
M vasopressin plus the indicated concentrations
of epinephrine. The response for vasopressin
alone (100%) was 970 6 107 pmol/106 cells in
initial IMCD segments and 1230 6 156 pmol/
106 cells in terminal IMCD segments. Each
point represents the mean of 4 to 9
experiments 6 SEM. Each experiment was
performed in quintuplicate.
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and IMCDt segments and urea transport in the IMCDt via
cAMP-dependent mechanisms [7]. Vasopressin-stimulated
cAMP formation in fresh and cultured IMCD cells is
mediated by V2 receptors [14]. In our study, cAMP accu-
mulation in response to V2 receptor stimulation approxi-
mately twofold greater in IMCDt versus IMCDi cells in
freshly isolated preparations. Using a single vasopressin
concentration, Isozaki et al [15] also showed that the cAMP
response of fresh microdissected IMCDt segments was
higher versus comparable IMCDi segments. Interestingly,
our study showed that this difference was eliminated when
the cells were cultured for five days. The EC50 for vaso-
pressin was also significantly blunted in cultured versus
fresh IMCDi and IMCDt cells. We attribute this attenua-
tion to the fact that renal epithelial cells orient themselves
with the basolateral (V2 receptor-containing) membrane
facing the culture substrate. Thus a higher concentration of
the vasopressin peptide was needed in cultured prepara-
tions to diffuse through the confluent monolayers and
stimulate the V2 receptors. In similar studies with A6 cells,
we have noted that the potency of vasopressin is higher in
cells grown on permeable versus impermeable surfaces,
supporting the above ideas (Jeffries and Floridia, unpub-
lished results). The increased maximum response to vaso-
pressin in fresh IMCDt versus IMCDi cells could be due to
a higher number of vasopressin receptors, or an increase in
the coupling efficiency of V2 receptors in the IMCDt
compared to IMCDi. Alternatively, vasopressin could si-
multaneously activate inhibitory oxytocin receptors in
IMCD cells. In cultured IMCD cells it has been demon-
strated that stimulation of oxytocin receptors by vasopres-
sin can reduce cAMP formation stimulated by V2 receptor
occupation via phospholipase C-mediated crosstalk [20,
21]. It is possible that such crosstalk could play a less
prominent role in the terminal versus the initial IMCD,
leading to greater V2-receptor-simulated cAMP formation
in the IMCDt. Further investigation is needed to define
vasopressin signaling and the relationship between V2 and
oxytocin receptors in the discrete segments of the IMCD.
Epinephrine and norepinephrine stimulate adenylyl cy-
clase by activating b-adrenoceptors in the collecting duct.
In the cortical collecting duct, b-adrenoceptors are presum-
ably located on intercalated cells [22], where they play a
role in Cl2 reabsorption [11] and K1 secretion [12].
b-Adrenoceptor-mediated cAMP formation has been de-
scribed in IMCD cells cultured from the entire medulla [9],
but the cellular location and functional role for these
receptors have not been identified. Teitelbaum, Strasheim
and Berl [9] tentatively identified the receptor expressed by
cultured IMCD cells to be of the b2 subtype; however, we
have recently demonstrated the expression of functional b1
and b2-adrenoceptors by cultured rat IMCD cells using
cAMP assays, radioligand binding and molecular biological
techniques [13]. In the present study, we sought to confirm
which segment(s) and cell types of the IMCD express
b-adrenoceptors. We originally hypothesized that b-adre-
noceptors would be present only in the IMCDi, since this
segment possesses intercalated cells and the IMCDt does
not. However, our results suggest that both the IMCDi and
IMCDt express functional b-adrenoceptors, the response
of which is enhanced in primary culture. We cannot be
certain of the cellular identity of the cells producing
b-adrenoceptor-mediated cAMP formation in the IMCDi.
However, the fact that the IMCDt is sensitive to isoproter-
enol suggests that the IMCD cell type also produces
functional b-adrenoceptors.
Our results also suggest that cell culture models may
overestimate the relative magnitude of the response to
b-adrenoceptor stimulation in IMCDi and IMCDt seg-
ments (Fig. 2). The maximum response to b-adrenoceptor
stimulation was 17 to 19% of the maximum response to
vasopressin in cultured IMCD cells; however the maximum
Fig. 4. Inhibition of isoproterenol-stimulated
cAMP accumulation by a2-adrenoceptor
stimulation in initial (IMCDi; F) and terminal
(IMCDt; E) inner medullary collecting duct
cells. (A) Freshly isolated cells. Each point
represents the response of 1025 M isoproterenol
plus the indicated concentrations of
epinephrine. The response for isoproterenol
alone (100%) was 40.1 6 4.1 pmol/106 cells in
initial IMCD segments and 33.6 6 4.1 pmol/106
cells in terminal IMCD segments. (B) Cells in
culture. The response for isoproterenol alone
was 189 6 18 pmol/106 cells in initial IMCD
segments and 213 6 25 pmol/106 cells in
terminal IMCD segments. Each point
represents the mean of at least three
experiments 6 SEM. Each experiment was
performed in quintuplicate.
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response to isoproterenol was only 3 to 6% of the maxi-
mum vasopressin response in fresh IMCD segments. Thus
it appears that the influence of b-adrenoceptors on cAMP
generation in vivo is likely to be small. Although cultured
IMCD cells present an interesting model to study renal
b-adrenoceptors, this model may not accurately reflect
physiological conditions in vivo.
Adenylyl cyclase activation in cortical, outer and inner
medullary segments of the rat collecting duct can be
inhibited by the concomitant activation of a2-adrenocep-
tors [8]. Stimulation of a2-adrenoceptors causes inhibition
of adenylyl cyclase and blunts the action of hormones that
rely on increased cAMP levels for signaling. Studies using
the isolated perfused kidney [23], micropuncture [24] and
perfused segments [25] have shown that a2-adrenoceptor
agonists inhibit vasopressin-stimulated water transport in
the rat collecting duct. In the cortical collecting duct,
a2-adrenoceptors are likely located on principal cells, since
their activation inhibits vasopressin-induced cAMP forma-
tion [26, 27] and water and Na reabsorption. a2-Adreno-
ceptors do not appear to be expressed by intercalated cells
in the cortical collecting duct, since a2-adrenoceptor ago-
nists do not block isoproterenol-induced cAMP formation
in this segment [22, 26]. a2-Adrenoceptor stimulation in-
hibits the effects of vasopressin in microdissected papillary
collecting duct [28, 29] and in cultured [9, 10] IMCD cells,
but a distinction between IMCDi and IMCDt had not been
investigated. We have recently demonstrated using radio-
ligand binding, Northern blot analysis and cAMP accumu-
lation that the a2-adrenoceptor in the IMCD is of the a2B
subtype. In the present study we showed that functional
a2-adrenoceptors were present in both the IMCDi and
IMCDt. Thus, it is likely that the principal cells of the
IMCDi and the IMCD cells of the IMCDt each express
a2-adrenoceptors. Interestingly, the response to a2-adreno-
ceptor activation was significantly diminished when IMCDi
and IMCDt cells were placed in primary culture.
a2-Adrenoceptor stimulation inhibits vasopressin-stimu-
lated cAMP accumulation in both IMCDi and IMCDt cells.
This suggests that these receptors may play a role in
regulation of vasopressin-mediated events in the IMCDt,
such as urea reabsorption. This idea is consistent with the
finding reported by Maeda et al [30] that in isolated
perfused IMCDt segments a2-adrenoceptor stimulation
reduced vasopressin-induced increases in urea permeabil-
ity. These authors further found that a2-adrenoceptor
stimulation lowered vasopressin-stimulated cAMP accumu-
lation in IMCDt segments, similar to our results in the
present study. However, it is not yet certain whether the
effects of a2-adrenoceptor stimulation on cAMP accumu-
lation lead to the regulation of water and urea permeabil-
ity. Rouch and Kudo [31, 32] recently reported that a2-
adrenoceptor stimulation in perfused IMCD segments
could reverse the effects of both vasopressin and non-
hydrolyzable cAMP analogues. These authors provide evi-
dence for a role for both prostanoids and protein kinase C
in a2-adrenoceptor-mediated inhibition of the action of
vasopressin [32]. Thus, the relationship between the role of
adenylyl cyclase and other pathways in the transduction of
a2-adrenoceptor-mediated effects in the IMCDi and
IMCDt remains to be determined.
A primary purpose of the present study was to examine
the validity of cultured IMCDi and IMCDt cells as models
for hormone signaling studies. Our results showed that
each of the elements (V2 receptors, a2- and b-adrenocep-
tors) of native tissue was present in cultured cells and
produced qualitatively similar responses; however, the
quantitative relationships among the responses were fun-
damentally changed. With one exception (vasopressin-
stimulated cAMP formation in IMCDt cells), responses
mediated via Gs, the stimulatory guanine nucleotide bind-
ing protein, were augmented in culture. Most striking was
the maximum response to isoproterenol, which increased
dramatically (5- to 6-fold) when either IMCDi or IMCDt
cells were placed in primary culture. On the other hand,
inhibition of adenylyl cyclase by a2-adrenoceptor activa-
tion, which is mediated via Gi, the inhibitory guanine
nucleotide binding protein, was markedly blunted following
five days of primary culture. We have also noted a reduc-
tion in the response to a2-adrenoceptor stimulation in
cultured versus freshly isolated proximal tubule cells (un-
published observations). The mechanism(s) for these
changes in phenotypic expression is unknown, but could be
related to altered receptor density and/or G protein cou-
pling. We have noted that in cells cultured from the entire
medulla that the density of a2B-adrenoceptors is lower than
that of native tissue [10]. The mechanisms for the afore-
mentioned phenotypic changes are unknown. Cell prolifer-
ation, growth factors, autocrine mediators, differences be-
tween in vivo versus in vitro osmolality or other changes
could cause the differences we see in cultured versus fresh
cells. These possibilities await investigation. However our
results point out that caution must be exercised when using
cell culture models to investigate signaling events that take
place in vivo.
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